Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma
about
sameAs
Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseasesHigh levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistancePlasma membrane transporters in modern liver pharmacologyMultidrug Resistance Proteins (MRPs) and Cancer TherapyDifferential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anionsA naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporterIdentification of a functional antioxidant response element within the eighth intron of the human ABCC3 geneEstablishment of a human hepatoma multidrug resistant cell line in vitroHCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinomaInhibition of hepatic tumor cell proliferation in vitro and tumor growth in vivo by taltobulin, a synthetic analogue of the tripeptide hemiasterlin.Enhanced therapeutic effects of combined chemotherapeutic drugs and midkine antisense oligonucleotides for hepatocellular carcinomaUpdate information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.Analysis of gene expression profiles as a tool to uncover tumor markers of liver cancer progression in a rat model.The MRP family of drug efflux pumps.Differential Expression of Ion Channels and Transporters During Hepatocellular Carcinoma Development.Inhibitor of DNA-binding 4 contributes to the maintenance and expansion of cancer stem cells in 4T1 mouse mammary cancer cell line.Regulation of hepatic ABCC transporters by xenobiotics and in disease states.The Blockage of KCa3.1 Channel Inhibited Proliferation, Migration and Promoted Apoptosis of Human Hepatocellular Carcinoma CellsThe ABC transporters MDR1 and MRP2: multiple functions in disposition of xenobiotics and drug resistance.Testing an aflatoxin B1 gene signature in rat archival tissues.Hepatobiliary transport in health and diseaseMolecular diagnosis of ATP-binding cassette transporter-related diseases.Modulation of oral drug bioavailability: from preclinical mechanism to therapeutic application.Role of efflux pumps and metabolising enzymes in drug delivery.Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT.Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins.Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition.Mechanisms of doxorubicin resistance in hepatocellular carcinomaMultifactorial nature of hepatocellular carcinoma drug resistance: could plant polyphenols be helpful?Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma.Drug transporter pharmacogenetics in nucleoside-based therapies.Multidrug resistance associated proteins in multidrug resistance.ATP-binding cassette transporters in liver.New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug disposition.MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma.Overexpression of ABCC3 promotes cell proliferation, drug resistance, and aerobic glycolysis and is associated with poor prognosis in urinary bladder cancer patients.Effect of Liver Disease on Hepatic Transporter Expression and Function.Effects of 3β-acethyl tormentic acid (3ATA) on ABCC proteins activity.Involvement of the epidermal growth factor receptor in the modulation of multidrug resistance in human hepatocellular carcinoma cells in vitro
P2860
Q24601963-B6D04CAA-CA00-40C1-9454-1A9884F56983Q24623958-B4E6AFC0-5595-45C7-8A10-1293AB9A7F62Q26829263-423F594A-397F-46BF-A7BF-5F28E24D6687Q26992204-1271A875-F7BD-4304-BE1B-5DCE8737ED22Q28155855-CE4B1A89-DAB8-4CC3-ABBD-81AF70C233AFQ28219109-B6D9C1C4-36DC-45AA-92C1-005475E30C27Q28250453-FB74EFA5-6F8A-47E0-B20E-07730A41E7E1Q33574625-91A09C18-1F09-48E7-87C1-FC0F5647B8C5Q33779140-F5CCBED9-33A6-469F-8014-2CAAB64F1DCBQ33866286-FAB6C638-00E9-46D3-985D-7BBF4E939179Q34099481-BF45A241-B2F4-40EF-B17B-9424E0E1E1D1Q34204238-3358C1B5-3A24-48CC-AB39-5A3BB832EC4EQ34632966-F3045154-F021-49A1-AB34-47F4778175E2Q35180104-6D4AC5DB-E766-4125-B1F0-92F16B2B2560Q35567296-8FD5AEAC-29C7-4BE1-81A5-AE14F7E2E247Q35595247-EBA23082-DA01-49BF-AA2D-9642C3BF501DQ35653415-C2996968-9CC1-48A4-AB88-371AF8C528BDQ35690177-F1A5AD34-CA36-46DB-BBAF-942485E9DF88Q35739537-15910A04-4C62-4D57-BCA2-9A67566D7CB1Q35956193-820B4F31-0605-484C-B323-AD5B456E7975Q35981453-A564D998-65D7-4519-A5FE-C4DBA4D62F19Q36126750-A6D80E8D-1102-49E0-92E4-8FEB1B685DF7Q36252201-E6591BC2-4FBA-4349-B0B3-E2CE46789DECQ36271954-2E4D14E4-B4E0-4B5F-9643-95929BEB6140Q36316872-537EFD97-9365-4E46-AEB4-EBB99E1B52CEQ36326113-F08BD863-BAEF-45F7-AC16-56AA9CE5A6F5Q36525551-F8955E74-E70F-46D0-9647-39645D4E3AFFQ36544905-657E7FC9-0D95-414F-A4E5-F6F6CF761E14Q36687760-4C70CE6D-FF20-4A24-AB37-2A46D8BB2257Q36804306-E7086227-0792-460D-A3DE-5A4F64F0A17FQ37218229-FA5B2A9B-775A-48B8-8623-1C0641888ACCQ37760954-A513775A-6E48-4656-B151-8B786A772754Q37958163-890777EC-3C33-47B6-AB38-D9E98E3FA0B1Q38150795-AB8222EC-1134-486C-92A6-D63652C5EF45Q38266172-D3DA6B42-2396-46E9-B44A-7F02FF183905Q38803437-D59E7B5D-85C5-48A4-AA41-E854D5FDFE0EQ38806337-57FF828A-F292-4110-BA16-9483935D2F0CQ38808182-AEEF0533-8B8B-4357-87F4-B0ABACD046CFQ39307419-026652E0-B353-4551-A154-AD6B51C1E7DBQ39531950-98AE5AE7-F296-4554-8332-B9F41F99C0B3
P2860
Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Expression of the multidrug re ...... human hepatocellular carcinoma
@ast
Expression of the multidrug re ...... human hepatocellular carcinoma
@en
Expression of the multidrug re ...... human hepatocellular carcinoma
@nl
type
label
Expression of the multidrug re ...... human hepatocellular carcinoma
@ast
Expression of the multidrug re ...... human hepatocellular carcinoma
@en
Expression of the multidrug re ...... human hepatocellular carcinoma
@nl
prefLabel
Expression of the multidrug re ...... human hepatocellular carcinoma
@ast
Expression of the multidrug re ...... human hepatocellular carcinoma
@en
Expression of the multidrug re ...... human hepatocellular carcinoma
@nl
P2093
P356
P1476
Expression of the multidrug re ...... human hepatocellular carcinoma
@en
P2093
P304
P356
10.1002/IJC.1498
P407
P50
P577
2001-11-01T00:00:00Z